Explore chapters and articles related to this topic
Psychotropic-Induced Weight Gain: Liability, Mechanisms and Treatment Approaches
Published in Susan L. McElroy, David B. Allison, George A. Bray, Obesity and Mental Disorders, 2006
Roger S. McIntyre, Jakub Z. Konarski, Paul E. Keck
It is estimated that approximately 10% of body weight may be lost over six months with successful implementation of dietary, exercise, and behavioral modification techniques. This foregoing weight loss may appear modest, but is sufficient to improve obesity-associated morbidity (225). For most patients, sustaining weight loss is an insurmountable objective that contributes to patient and health care provider disappointment and nihilism (226,227). Pharmacotherapy has been recommended if behavioral strategies are insufficient in achieving therapeutic objectives after six months (221).
Elevated adiponectin predicts the development of rheumatoid arthritis in subjects with obesity
Published in Scandinavian Journal of Rheumatology, 2020
Y Zhang, M Peltonen, JC Andersson-Assarsson, P-A Svensson, C Herder, A Rudin, LMS Carlsson, C Maglio
The Swedish Obese Subjects (SOS) study is a longitudinal non-randomized controlled study designed to examine the effect of bariatric surgery on obesity-associated morbidity and overall mortality (24–26). In this cohort of subjects with obesity, we have previously analysed the effect of bariatric surgery on the future development of RA, since obesity is thought to be a risk factor for the development of the disease, in particular if combined with other factors (27, 28). However, we were not able to detect any association between bariatric surgery and the incidence of RA (29). Serum adiponectin levels have been measured in SOS study participants at baseline and at 2 and 10 year follow-up, and this has allowed us to study the association between circulating adiponectin and the development of RA in subjects with obesity. Thus, the aim of the current report was to determine whether elevated serum adiponectin levels predict the development of RA in these subjects.
Prevalence of overweight and obesity among selected schoolchildren and adolescents in Cofimvaba, South Africa
Published in South African Journal of Clinical Nutrition, 2021
Olufunmilola Otitoola, Wilna Oldewage-Theron, Abdul Egal
Childhood obesity has become a growing global epidemic.1 In 2010 it was estimated that 43 million children were overweight and obese with 81% of these coming from developing countries. It was projected that by 2020 almost 1 in 10 children worldwide and 1 in 8 children in Africa will either be overweight or obese. Childhood obesity has been reported to be higher among South African children (17.1% to 22.8%).2 Adolescence (10–19 years), a transition phase between childhood and adulthood, is a critical period for the onset of obesity and for obesity-associated morbidity in later life.3